Morrison & Foerster's Dave Lynn and Marty Dunn provide a brief update about the U.S. Securities and Exchange Commission's recent MD&A interpretive release regarding key performance indicators and metrics disclosures, as well as the changes in practice for seeking confidential treatment of information filed with the SEC.
Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP. All rights reserved